Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 1,788.00
-23.00 (-1.27%)
Aug 14, 2025, 3:44 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.01 billion as of August 14, 2025. Its market cap has decreased by -4.87% in one year.
Market Cap
4.01B
Enterprise Value
4.98B
Revenue
2.35B
Ranking
n/a
PE Ratio
14.87
Stock Price
1,788.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.01B, an increase of 753.96%. That is a compound annual growth rate of 11.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.91B |
| GSK plc | 56.34B |
| Haleon | 31.86B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.64B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 1.92B |
| Genus | 1.64B |